Oral tyrosine kinase inhibitor for neovascular age-related macular degeneration: A phase 1 dose-escalation study

Timothy L. Jackson, David Boyer, David M. Brown, Nauman Chaudhry, Michael Elman, Chris Liang, Denis O'Shaughnessy, Edward C. Parsons, Sunil Patel, Jason S. Slakter, Philip J. Rosenfeld

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Oral tyrosine kinase inhibitor for neovascular age-related macular degeneration: A phase 1 dose-escalation study'. Together they form a unique fingerprint.

Medicine & Life Sciences